Level C· Early human research exploring benefitsRetrospective StudyEurope PMCOpen access

Autologous micro-fragmented adipose tissue associated with arthroscopy in moderate-severe knee osteoarthritis: outcome at two year follow-up

Giorgini A., Selleri F., Zambianchi F., Cataldo G., Francioni E., Catani F.

Retrospective Study with a reported sample of 49 on Knee Osteoarthritis, Osteoarthritis, Cartilage Damage, Meniscus Injury, published in BMC Musculoskelet Disord (2022) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Retrospective Study
Journal
BMC Musculoskelet Disord (2022)
Reported sample size
49
Source database
Europe PMC
PMID
36348344
PMCID
PMC9641752
DOI
10.1186/s12891-022-05921-6
Citations
8

Abstract (original English)

Background Adipose tissue has recently gained growing interest in the treatment of osteoarthritis (OA). The aim of the present study was to evaluate the efficacy of a single injection of autologous micro-fragmented adipose tissue (aMFAT) associated with arthroscopy (cartilage debridement/meniscal regularization or selective meniscectomy/micro-drilling) for symptomatic knee OA. Methods This retrospective, single-center study included 49 patients (50 knees) affected by knee OA (radiographic Kellgren-Lawrence III-IV) treated with a single injection of autologous micro-fragmented adipose tissue and knee arthroscopy. Knee Injury and Osteoarthritis Outcome Score (KOOS) and subjective International Knee Documentation Committee (IKDC) score were the primary outcome measures and were collected at one and 2 years post-operatively. Patients were divided into clusters based on age, complexity of arthroscopic procedures and chondral lesion grade. Results Four patients underwent knee replacement (8%). No major adverse events were reported. Minimal Clinically Important Difference (MCID) for KOOS and IKDC was reached by 84 and 74% of all cases at 1 year and by 80 and 76% at 2 years, respectively. High grade chondral lesions negatively affected the outcome at 2 years follow-up (p Conclusion The injection of micro-fragmented adipose tissue associated with arthroscopy demonstrated to be a safe an

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
Knee JointAdipose TissueHumansOsteoarthritis, KneeArthroscopyTreatment OutcomeRetrospective StudiesFollow-Up Studies

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research